Oncotarget

Case Reports:

Genomic profile of pulmonary follicular dendritic cell sarcoma: a case report and systematic review

PDF  |  Full Text  |  How to cite

DOI pending

Metrics: PDF 774 views  |  Full Text 902 views

Liyuan Fan1,2, Hongsheng Li2, Minghao Li1,2, Yang Zhang2, Jianping Zhang3 and Baosheng Li2

1Cheeloo College of Medicine, Shandong University, Jinan, China

2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China

3Department of Pathology, Qilu Hospital, Shandong University, Jinan, China

Correspondence to:

Baosheng Li, email: [email protected]

Keywords: pulmonary FDCS; copy number variants; high-throughput sequencing; tumor genomic profiling; REL

Received: June 22, 2017    Accepted: December 28, 2017    Published: January 02, 2018

ABSTRACT

Follicular dendritic cell sarcoma (FDCS) is an extremely rare neoplasm which involves both nodal and extranodal sites. The demographics, pathological characteristics and clinical features of this tumor have been reported a lot, but the genomic information is still insufficient.

Here we presented the ninth case of pulmonary FDCS in English publication, whose diagnosis has been revised from “synovial sarcoma” to FDCS. The patient underwent a right pneumonectomy and died of sudden cardiac death within a week after the surgery. Because of the lack of genomic characterization of the tumor, we used the OncoScan®gene chip, which has been optimized for detection of whole genome CNVs. By bioinformatics’ analysis and thoroughly literature review, we found the following suspicious functional genes REL, TET2, CREBBP and CYLD. These genes we found may have important influence on the fate of the neoplasm. Further study for their role of diagnostic and therapeutic targets is needed.